calcium pyrophosphate has been researched along with methotrexate in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bertino, JR; Carr, F; Dube, S; Medina, WD | 1 |
| Al-Duaij, A; Moore, AR; Sedgwick, AD; Willoughby, DA | 1 |
| Announ, N; Guerne, PA | 2 |
| Abhishek, A; Doherty, M | 1 |
| Andrés, M; Pascual, E; Sivera, F | 2 |
| Rosenthal, AK; Ryan, LM | 1 |
| Kakoullis, L; Papachristodoulou, E; Parperis, K; Rosenthal, AK | 1 |
5 review(s) available for calcium pyrophosphate and methotrexate
| Article | Year |
|---|---|
Treating difficult crystal pyrophosphate dihydrate deposition disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Chondrocalcinosis; Colchicine; Glucocorticoids; Humans; Magnesium Compounds; Methotrexate; Probenecid; Uricosuric Agents | 2008 |
Pathophysiology of articular chondrocalcinosis--role of ANKH.
Topics: Animals; Ankylosis; Calcium Pyrophosphate; Chondrocalcinosis; Crystallization; Humans; Hydroxychloroquine; Interleukin-1; Methotrexate; Mutation; Phosphate Transport Proteins; Risk Factors | 2011 |
Current advances in therapies for calcium pyrophosphate crystal arthritis.
Topics: Antirheumatic Agents; Arthritis; Biological Products; Calcium Pyrophosphate; Chondrocalcinosis; Crystallization; Glucocorticoids; Humans; Interleukin-1beta; Methotrexate | 2016 |
Calcium Pyrophosphate Deposition Disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Cartilage; Chondrocalcinosis; Crystallization; Diagnostic Errors; Glucocorticoids; Humans; Injections, Intra-Arterial; Methotrexate; Prevalence; Radiography; Risk Factors; Terminology as Topic | 2016 |
Management of calcium pyrophosphate crystal deposition disease: A systematic review.
Topics: Aged; Calcium Pyrophosphate; Chondrocalcinosis; Colchicine; Gout; Humans; Methotrexate; Randomized Controlled Trials as Topic | 2021 |
4 other study(ies) available for calcium pyrophosphate and methotrexate
| Article | Year |
|---|---|
Genetic transformation of murine bone marrow cells to methotrexate resistance.
Topics: Animals; Calcium Phosphates; Cell Line; DNA; Drug Resistance; Female; Genetic Engineering; Hematopoietic Stem Cells; Methotrexate; Mice; Mice, Inbred CBA | 1983 |
Studies into the association between leucocyte accumulation and oedema formation.
Topics: Animals; Calcium Pyrophosphate; Carrageenan; Cell Movement; Edema; Leukocyte Count; Leukocytes; Male; Methotrexate; Pleural Effusion; Rats; Rats, Inbred Strains; Zymosan | 1985 |
[Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Cartilage, Articular; Chondrocalcinosis; Colchicine; Diagnosis, Differential; Disease Progression; Glucocorticoids; Gout Suppressants; Humans; Injections, Intra-Articular; Interleukin-1beta; Methotrexate; Middle Aged; Risk Factors; Synovial Membrane | 2007 |
Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease?
Topics: Arthritis; Calcium Pyrophosphate; Chondrocalcinosis; Chronic Disease; Female; Humans; Male; Methotrexate; Risk Assessment; Sampling Studies; Severity of Illness Index; Treatment Outcome | 2015 |